High Impact Publications Award

MUSC Hollings Cancer Center enthusiastically supports its members’ impactful discoveries and publications and has developed the High Impact Publications Award to recognize excellence on a yearly basis. Hollings leadership will select these publications from nominations that have appeared in high impact journals with a Hollings member as the first or a primary author. Please use the nomination form to submit a publication for consideration.

Eligibility and Criteria | Review Committee | Timeline | Awardees

Eligibility and Criteria

  • Must be a Hollings member.
  • Work must have been completed at MUSC.
  • Must be cancer related, but preference will be given to translational science.
  • Nominations can be submitted by colleagues or self-nominations.
  • The publication must have appeared in a high impact journal or e-published within the past previous academic year (July 1 through June 30). Manuscripts will be accepted if they produce an official letter of acceptance.
  • Must not have been awarded the MUSC College of Medicine’s Research Excellence Award for the same publication.
  • Two publications will be honored per year for the previous academic year.
  • Awardees will have a plaque displayed within the Hollings Cancer Center, and be given the opportunity to present at the annual Hollings Research Retreat.

Review Committee

Committee members were nominated by the Hollings research program leaders. Two members were selected per program.

  • Cancer Biology: Joe Delaney, Ph.D., and Visu Palanisamy, Ph.D.
  • Cancer Control: Jennifer Dahne, Ph.D., and Evan Graboyes, M.D.
  • Cancer Immunology: Brian Hess, M.D., and Jessica Thaxton, Ph.D.
  • Developmental Cancer Therapeutics: Jen Wang, Ph.D., and John Wrangle, M.D.


The deadline for nominations is Monday, August 23, 2021, by 4 p.m. Selections will be made and awardees will be notified by late September or early October.